Patent · US Active

Lymphocyte activation gene-3 (LAG-3) binding antibody and use thereof

US11840568B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

MAB-VENTURE BIOPHARM CO., LTD. · CN

Inventors

Shaoxiong Wang · Shanghai, CN
John Liuzhong Xu · Shanghai, CN
Jing Zhao · Shanghai, CN
Ming Wang · Beijing, CN
Juehua Xu · Shanghai, CN
Fei Song · San Jose, US

Key dates

Filing date	Apr 1, 2019
Grant date	Dec 12, 2023
Priority date	—
Expiry date	Sep 18, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to an antibody binding to lymphocyte activation gene-3 (LAG-3) and use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.